Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 69776 - 69800 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Silicon dioxide	Approved	CCDC80	151887	downregulated	Silicon Dioxide analog results in decreased expression of CCDC80 mRNA	3q13.2	A24195
Silicon dioxide	Approved	CCDC81	60494	downregulated	Silicon Dioxide analog results in decreased expression of CCDC81 mRNA	11q14.2	A24195
Silicon dioxide	Approved	CCDC84	338657	upregulated	Silicon Dioxide analog results in increased expression of CCDC84 mRNA	11q23.3	A24195
Silicon dioxide	Approved	CCDC85A	114800	downregulated	Silicon Dioxide analog results in decreased expression of CCDC85A mRNA	2p16.1	A24195
Silicon dioxide	Approved	CCDC85B	11007	upregulated	Silicon Dioxide analog results in increased expression of CCDC85B mRNA	11q13.1	A24195
Silicon dioxide	Approved	CCDC85B	11007	upregulated	Silicon Dioxide results in increased expression of CCDC85B mRNA	11q13.1	A24197 A24196
Silicon dioxide	Approved	CCDC86	79080	upregulated	Silicon Dioxide analog results in increased expression of CCDC86 mRNA	11q12.2	A24195
Silicon dioxide	Approved	CCDC93	54520	upregulated	Silicon Dioxide results in increased expression of CCDC93 mRNA	2q14.1	A24196
Silicon dioxide	Approved	CCK	885	upregulated	Silicon Dioxide analog results in increased expression of CCK mRNA	3p22.1	A24195
Silicon dioxide	Approved	CCL17	6361	upregulated	Silicon Dioxide analog results in increased expression of CCL17 mRNA	16q21	A24194
Silicon dioxide	Approved	CCL17	6361	downregulated	Silicon Dioxide results in decreased expression of CCL17 mRNA	16q21	A24203
Silicon dioxide	Approved	CCL19	6363	downregulated	Silicon Dioxide results in decreased expression of CCL19 mRNA	9p13.3	A24203
Silicon dioxide	Approved	CCL2	6347	upregulated	Silicon Dioxide analog results in increased expression of CCL2 mRNA	17q12	A24194 A24195
Silicon dioxide	Approved	CCL2	6347	upregulated	Silicon Dioxide results in increased expression of CCL2 mRNA	17q12	A24204
Silicon dioxide	Approved	CCL20	6364	upregulated	Silicon Dioxide analog results in increased expression of CCL20 mRNA	2q36.3	A24194 A24195
Silicon dioxide	Approved	CCL20	6364	upregulated	Silicon Dioxide results in increased expression of CCL20 mRNA	2q36.3	A24203 A24200 A24205 A24196
Silicon dioxide	Approved	CCL21	6366	downregulated	Silicon Dioxide results in decreased expression of CCL21 mRNA	9p13.3	A24203
Silicon dioxide	Approved	CCL24	6369	downregulated	Silicon Dioxide results in decreased expression of CCL24 mRNA	7q11.23	A24203
Silicon dioxide	Approved	CCL4	6351	upregulated	Silicon Dioxide analog results in increased expression of CCL4 mRNA	17q12	A24194
Silicon dioxide	Approved	CCL5	6352	upregulated	Silicon Dioxide analog results in increased expression of CCL5 mRNA	17q12	A24194 A24195
Silicon dioxide	Approved	CCL5	6352	upregulated	Silicon Dioxide results in increased expression of CCL5 mRNA	17q12	A24196
Silicon dioxide	Approved	CCL7	6354	downregulated	Silicon Dioxide analog results in decreased expression of CCL7 mRNA	17q12	A24195
Silicon dioxide	Approved	CCNA2	890	downregulated	Silicon Dioxide analog results in decreased expression of CCNA2 mRNA	4q27	A24194
Silicon dioxide	Approved	CCNB1	891	upregulated	Silicon Dioxide results in increased expression of CCNB1 mRNA	5q13.2	A24196
Silicon dioxide	Approved	CCND1	595	downregulated	Silicon Dioxide analog results in decreased expression of CCND1 mRNA	11q13.3	A24194

Displaying entries 69776 - 69800 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability